The Role of Central Serotonergic Dysfunction in the Aetiology of Premenstrual Dysphoric Disorder: Therapeutic Implications

Author： Parry B.L.

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.4, 2001-01, pp. : 277-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests

By Inoue Y. Terao T. Iwata N. Okamoto K. Kojima H. Okamoto T. Yoshimura R. Nakamura J.

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 213-219

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions

By Ross Lori E Steiner Meir

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1491-1499

Informa Healthcare

Access to resources Recommend Favorite

Premenstrual dysphoric disorder: is it simply PMS?

By Endicott J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 259-259

Elsevier

Access to resources Recommend Favorite

Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder

By Praschak-Rieder N. Willeit M. Winkler D. Neumeister A. Hilger E. Zill P. Hornik K. Stastny J. Thierry N. Ackenheil M. Bondy B. Kasper S.

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 129-134

Elsevier

Access to resources Recommend Favorite

Duloxetine for premenstrual dysphoric disorder: a pilot study

By Mazza Marianna Harnic Desiree Catalano Valeria Janiri Luigi Bria Pietro

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 517-521

Informa Healthcare

Access to resources Recommend Favorite